Cargando…

Impairment of muscular endothelial cell regeneration in dermatomyositis

BACKGROUND AND AIM: Inflammatory myopathies are heterogeneous in terms of etiology, (immuno)pathology, and clinical findings. Endothelial cell injury, as it occurs in DM, is a common feature of numerous inflammatory and non-inflammatory vascular diseases. Vascular regeneration is mediated by both lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemmer, D., Schmidt, J., Kummer, K., Lemmer, B., Wrede, A., Seitz, C., Balcarek, P., Schwarze, K., Müller, G. A., Patschan, D., Patschan, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623165/
https://www.ncbi.nlm.nih.gov/pubmed/36330424
http://dx.doi.org/10.3389/fneur.2022.952699
_version_ 1784821936306520064
author Lemmer, D.
Schmidt, J.
Kummer, K.
Lemmer, B.
Wrede, A.
Seitz, C.
Balcarek, P.
Schwarze, K.
Müller, G. A.
Patschan, D.
Patschan, S.
author_facet Lemmer, D.
Schmidt, J.
Kummer, K.
Lemmer, B.
Wrede, A.
Seitz, C.
Balcarek, P.
Schwarze, K.
Müller, G. A.
Patschan, D.
Patschan, S.
author_sort Lemmer, D.
collection PubMed
description BACKGROUND AND AIM: Inflammatory myopathies are heterogeneous in terms of etiology, (immuno)pathology, and clinical findings. Endothelial cell injury, as it occurs in DM, is a common feature of numerous inflammatory and non-inflammatory vascular diseases. Vascular regeneration is mediated by both local and blood-derived mechanisms, such as the mobilization and activation of so-called proangiogenic cells (PACs) or early endothelial progenitor cells (eEPCs). The current study aimed to evaluate parameters of eEPC integrity in dermatomyositis (DM), compared to necrotizing myopathy (NM) and to non-myopathic controls. METHODS: Blood samples from DM and NM patients were compared to non-myositis controls and analyzed for the following parameters: circulating CD133(+)/VEGFR-2(+) cells, number of colony-forming unit endothelial cells (CFU-ECs), concentrations of angiopoietin 1, vascular endothelial growth factor (VEGF), and CXCL-16. Muscle biopsies from DM and NM subjects underwent immunofluorescence analysis for CXCR6, nestin, and CD31 (PECAM-1). Finally, myotubes, derived from healthy donors, were stimulated with serum samples from DM and NM patients, subsequently followed by RT-PCR for the following candidates: IL-1β, IL-6, nestin, and CD31. RESULTS: Seventeen (17) DM patients, 7 NM patients, and 40 non-myositis controls were included. CD133(+)/VEGFR-2(+) cells did not differ between the groups. Both DM and NM patients showed lower CFU-ECs than controls. In DM, intramuscular CD31 abundances were significantly reduced, which indicated vascular rarefaction. Muscular CXCR6 was elevated in both diseases. Circulating CXCL-16 was higher in DM and NM in contrast, compared to controls. Serum from patients with DM but not NM induced a profound upregulation of mRNS expression of CD31 and IL-6 in cultured myotubes. CONCLUSION: Our study demonstrates the loss of intramuscular microvessels in DM, accompanied by endothelial activation in DM and NM. Vascular regeneration was impaired in DM and NM. The findings suggest a role for inflammation-associated vascular damage in the pathogenesis of DM.
format Online
Article
Text
id pubmed-9623165
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96231652022-11-02 Impairment of muscular endothelial cell regeneration in dermatomyositis Lemmer, D. Schmidt, J. Kummer, K. Lemmer, B. Wrede, A. Seitz, C. Balcarek, P. Schwarze, K. Müller, G. A. Patschan, D. Patschan, S. Front Neurol Neurology BACKGROUND AND AIM: Inflammatory myopathies are heterogeneous in terms of etiology, (immuno)pathology, and clinical findings. Endothelial cell injury, as it occurs in DM, is a common feature of numerous inflammatory and non-inflammatory vascular diseases. Vascular regeneration is mediated by both local and blood-derived mechanisms, such as the mobilization and activation of so-called proangiogenic cells (PACs) or early endothelial progenitor cells (eEPCs). The current study aimed to evaluate parameters of eEPC integrity in dermatomyositis (DM), compared to necrotizing myopathy (NM) and to non-myopathic controls. METHODS: Blood samples from DM and NM patients were compared to non-myositis controls and analyzed for the following parameters: circulating CD133(+)/VEGFR-2(+) cells, number of colony-forming unit endothelial cells (CFU-ECs), concentrations of angiopoietin 1, vascular endothelial growth factor (VEGF), and CXCL-16. Muscle biopsies from DM and NM subjects underwent immunofluorescence analysis for CXCR6, nestin, and CD31 (PECAM-1). Finally, myotubes, derived from healthy donors, were stimulated with serum samples from DM and NM patients, subsequently followed by RT-PCR for the following candidates: IL-1β, IL-6, nestin, and CD31. RESULTS: Seventeen (17) DM patients, 7 NM patients, and 40 non-myositis controls were included. CD133(+)/VEGFR-2(+) cells did not differ between the groups. Both DM and NM patients showed lower CFU-ECs than controls. In DM, intramuscular CD31 abundances were significantly reduced, which indicated vascular rarefaction. Muscular CXCR6 was elevated in both diseases. Circulating CXCL-16 was higher in DM and NM in contrast, compared to controls. Serum from patients with DM but not NM induced a profound upregulation of mRNS expression of CD31 and IL-6 in cultured myotubes. CONCLUSION: Our study demonstrates the loss of intramuscular microvessels in DM, accompanied by endothelial activation in DM and NM. Vascular regeneration was impaired in DM and NM. The findings suggest a role for inflammation-associated vascular damage in the pathogenesis of DM. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9623165/ /pubmed/36330424 http://dx.doi.org/10.3389/fneur.2022.952699 Text en Copyright © 2022 Lemmer, Schmidt, Kummer, Lemmer, Wrede, Seitz, Balcarek, Schwarze, Müller, Patschan and Patschan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Lemmer, D.
Schmidt, J.
Kummer, K.
Lemmer, B.
Wrede, A.
Seitz, C.
Balcarek, P.
Schwarze, K.
Müller, G. A.
Patschan, D.
Patschan, S.
Impairment of muscular endothelial cell regeneration in dermatomyositis
title Impairment of muscular endothelial cell regeneration in dermatomyositis
title_full Impairment of muscular endothelial cell regeneration in dermatomyositis
title_fullStr Impairment of muscular endothelial cell regeneration in dermatomyositis
title_full_unstemmed Impairment of muscular endothelial cell regeneration in dermatomyositis
title_short Impairment of muscular endothelial cell regeneration in dermatomyositis
title_sort impairment of muscular endothelial cell regeneration in dermatomyositis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623165/
https://www.ncbi.nlm.nih.gov/pubmed/36330424
http://dx.doi.org/10.3389/fneur.2022.952699
work_keys_str_mv AT lemmerd impairmentofmuscularendothelialcellregenerationindermatomyositis
AT schmidtj impairmentofmuscularendothelialcellregenerationindermatomyositis
AT kummerk impairmentofmuscularendothelialcellregenerationindermatomyositis
AT lemmerb impairmentofmuscularendothelialcellregenerationindermatomyositis
AT wredea impairmentofmuscularendothelialcellregenerationindermatomyositis
AT seitzc impairmentofmuscularendothelialcellregenerationindermatomyositis
AT balcarekp impairmentofmuscularendothelialcellregenerationindermatomyositis
AT schwarzek impairmentofmuscularendothelialcellregenerationindermatomyositis
AT mullerga impairmentofmuscularendothelialcellregenerationindermatomyositis
AT patschand impairmentofmuscularendothelialcellregenerationindermatomyositis
AT patschans impairmentofmuscularendothelialcellregenerationindermatomyositis